|Bid||0.00 x 1800|
|Ask||0.00 x 800|
|Day's Range||43.56 - 44.88|
|52 Week Range||38.22 - 62.78|
|Beta (5Y Monthly)||0.53|
|PE Ratio (TTM)||13.38|
|Earnings Date||Nov 30, 2022 - Dec 05, 2022|
|Forward Dividend & Yield||1.04 (2.24%)|
|Ex-Dividend Date||Aug 12, 2022|
|1y Target Est||54.88|
Kroger said it has made several attempts since February to negotiate with the pharmacy benefit manager for a "more equitable and fair contract that lowers cost, increases access, and delivers greater transparency, but there has been little to no progress to date". Kroger said more than 90% of Kroger Health's customers will not be affected by a termination of the deal, but if a new agreement is not reached by Dec. 31, most Express Scripts' commercial customers won't be able to fill prescriptions at Kroger stores.
Grocery store chain Kroger Co. said Friday that it has sent insurer Cigna Corp. subsidiary Express Scripts Inc. a written notice of its plan to terminate their pharmacy provider agreement for commercial customers. "Express Scripts drug pricing model is unsustainable for Kroger and consumers; access to affordable prescriptions and wellness services remains company's top priority," Kroger said
Kroger Health, the healthcare division of The Kroger Co. (NYSE: KR), yesterday provided Express Scripts, Inc. (ESI), written notice of its intention to terminate their pharmacy provider agreement for commercial customers. Since February, Kroger has attempted on dozens of occasions to negotiate in good faith with ESI – seeking a more equitable and fair contract that lowers cost, increases access, and delivers greater transparency – but there has been little to no progress to date.